YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells.

scientific article published on October 2005

YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1535-7163.MCT-05-0090
P698PubMed publication ID16227413
P5875ResearchGate publication ID7539786

P50authorJih-Hwa GuhQ40601635
Yao-Ting HuangQ56154120
Che-Ming TengQ56996745
P2093author name stringSheng-Chu Kuo
Shiow-Lin Pan
Ya-Ling Chang
Fang-Yu Lee
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
P304page(s)1628-1635
P577publication date2005-10-01
P1433published inMolecular Cancer TherapeuticsQ2363144
P1476titleYC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells
P478volume4

Reverse relations

cites work (P2860)
Q84985820Bp5250 inhibits vascular endothelial growth factor-induced angiogenesis and HIF-1α expression on endothelial cells
Q39503219Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.
Q38772682Cytotoxic activity of the novel heterocyclic compound G-11 is primarily mediated through intrinsic apoptotic pathway.
Q33601510Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions
Q39790544Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells
Q39415018KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways
Q54405180Mutant p53 subverts p63 control over KLF4 expression in keratinocytes.
Q42377201Pharmacological HIF-inhibition attenuates postoperative adhesion formation
Q33587139Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage
Q35210888Retracted: Nuclear Factor Kappa-B Signaling Is Integral to Ocular Neovascularization in Ischemia-Independent Microenvironment
Q34637708Retracted: The Nexus between VEGF and NFκB Orchestrates a Hypoxia-Independent Neovasculogenesis
Q36642960The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
Q37767875The ubiquitin-proteasome system in prostate cancer and its transition to castration resistance
Q50104130Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
Q36052832YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia.
Q37493227YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma
Q37183795YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition
Q33821469YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells
Q36964934YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway
Q40184763YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia
Q42810913YC-1 rescues cancer cachexia by affecting lipolysis and adipogenesis.
Q39672848YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway.
Q64937707YC‑1 reduces inflammatory responses by inhibiting nuclear factor‑κB translocation in mice subjected to transient focal cerebral ischemia.

Search more.